Inhibiting TNF has shown remarkable therapeutic benefits in patients with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, juvenile arthritis and many other less prevalent diseases. Here, TNF is linked to ankylosing spondylitis.